Explores precision medicine advancements in cell death and immunity, indicating a collaborative approach.
Following the long tradition of Cell Death & Disease, interrupted only the the COVID-19 events, the CDDisease 12th Meeting: Precision Medicine Symposium, held on April 23–24, 2026 in Suzhou, China, was organized within the framework of the Italy–China bilateral initiative in precision medicine, promoted by the Heal Italia Foundation in collaboration with Cell Death & Disease (Springer Nature), and jointly organized by The Fourth Affiliated Hospital of Soochow University. The meeting, with two magistral keynote lectures by Junying Yuan (Shanghai Institute of Organic Chemistry, China) and John Silke (Walter and Eliza Hall Institute, Australia), brought together leading scientists and clinicians from diverse disciplines, providing a platform for interdisciplinary exchange and reflecting a growing global effort to advance precision medicine through international collaboration.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: